Newsroom | 1755 results

NEW YORK--(BUSINESS WIRE)--iHeartMedia and P&G announce the inaugural Elton John Impact Awards, celebrating trailblazing LGBTQ+ community members and prominent allies. Hosted by Billy Porter and Elvis Duran, the special will launch as a podcast series on the iHeartRadio app and everywhere podcasts are heard and as an audio special airing across iHeartRadio PRIDE stations on June 1. The Elton John Impact Awards recognizes those whose lifelong work has inspired change and shaped culture, whil...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, today announced the pricing of senior unsecured notes in an aggregate principal amount of $3 billion, in an underwritten, registered public offering, consisting of $500 million of 4.250% senior notes maturing in 2028, $1 billion of 4.400% senior notes maturing in 2029, $1 billion of 4.600% senior notes maturi...

LOS ANGELES--(BUSINESS WIRE)--Google's ‘Buyer Beware’ Policy Can Compromise Patient Confidentiality, says AHF...

LONG BEACH, Calif.--(BUSINESS WIRE)--New AHF Wellness Center Provides Crucial HIV and STI Services in Long Beach...

RICHMOND, Va.--(BUSINESS WIRE)--Anthem HealthKeepers Plus, in partnership with the Virginia Harm Reduction Coalition (VHRC), has launched a new initiative to expand access to naloxone through the placement of vending boxes in high-need areas across the Roanoke and Western Piedmont regions. The initiative is part of a broader effort to address the ongoing opioid crisis by increasing access to life-saving resources and supporting community-based harm reduction strategies. Through the partnership,...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter 2026. “Gilead teams have delivered another strong quarter with 8% year-over-year growth in our base business and 10% growth in HIV, supported by the successful launch of Yeztugo. We have raised our full year revenue guidance as a reflection of our performance," said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “Building on the strongest pipel...

LAS VEGAS--(BUSINESS WIRE)--The American Osteopathic Association (AOA) is thrilled to announce registration for the Osteopathic Medical Education Conference, more commonly known as OMED, is now open. This year’s in-person event will take place from Oct. 22-25, 2026, at Caesars Palace in Las Vegas, bringing together thousands of doctors of osteopathic medicine (DOs) and osteopathic medical students for an unparalleled experience of inspiration, learning, networking and professional growth. OMED...

LOS ANGELES--(BUSINESS WIRE)--Gilead's Earnings per Share Expected to Be Up 52% as Florida’s and other States’ AIDS Drug Programs Falters, says AHF...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) – an investigational, once-daily single-tablet combination regimen for the treatment of HIV in adults who are virologically suppressed. The FDA has granted priority review of the application and assigned a Prescription Drug User Fee Act (PDUFA) action date of Aug...

LOS ANGELES--(BUSINESS WIRE)--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities...